These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31928698)

  • 1. Immune responses in mice and pigs after oral vaccination with rabies virus vectored Nipah disease vaccines.
    Shuai L; Ge J; Wen Z; Wang J; Wang X; Bu Z
    Vet Microbiol; 2020 Feb; 241():108549. PubMed ID: 31928698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
    Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs.
    Kong D; Wen Z; Su H; Ge J; Chen W; Wang X; Wu C; Yang C; Chen H; Bu Z
    Virology; 2012 Oct; 432(2):327-35. PubMed ID: 22726244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
    Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
    Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdovirus-based vaccine platforms against henipaviruses.
    Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
    J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.
    Mire CE; Versteeg KM; Cross RW; Agans KN; Fenton KA; Whitt MA; Geisbert TW
    Virol J; 2013 Dec; 10():353. PubMed ID: 24330654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.
    Li Y; Li R; Wang M; Liu Y; Yin Y; Zai X; Song X; Chen Y; Xu J; Chen W
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32340278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.
    DeBuysscher BL; Scott D; Marzi A; Prescott J; Feldmann H
    Vaccine; 2014 May; 32(22):2637-44. PubMed ID: 24631094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease.
    Foster SL; Woolsey C; Borisevich V; Agans KN; Prasad AN; Deer DJ; Geisbert JB; Dobias NS; Fenton KA; Cross RW; Geisbert TW
    Proc Natl Acad Sci U S A; 2022 Mar; 119(12):e2200065119. PubMed ID: 35286211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the immunogenicity of an mRNA vectored Nipah virus vaccine candidate in pigs.
    Pedrera M; McLean RK; Medfai L; Thakur N; Todd S; Marsh G; Bailey D; Donofrio G; Muramatsu H; Pardi N; Weissman D; Graham SP
    Front Immunol; 2024; 15():1384417. PubMed ID: 38726013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice.
    Tian L; Yan L; Zheng W; Lei X; Fu Q; Xue X; Wang X; Xia X; Zheng X
    Vet Microbiol; 2021 Jun; 257():109076. PubMed ID: 33957572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant nipah virus vaccines protect pigs against challenge.
    Weingartl HM; Berhane Y; Caswell JL; Loosmore S; Audonnet JC; Roth JA; Czub M
    J Virol; 2006 Aug; 80(16):7929-38. PubMed ID: 16873250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.
    Yoneda M; Georges-Courbot MC; Ikeda F; Ishii M; Nagata N; Jacquot F; Raoul H; Sato H; Kai C
    PLoS One; 2013; 8(3):e58414. PubMed ID: 23516477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
    Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
    Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months.
    Pallister JA; Klein R; Arkinstall R; Haining J; Long F; White JR; Payne J; Feng YR; Wang LF; Broder CC; Middleton D
    Virol J; 2013 Jul; 10():237. PubMed ID: 23867060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the DNA immunogenicity of fusion and attachment glycoproteins of Nipah virus].
    Wang XJ; Ge JY; Wang QH; Hu S; Lin XM; Bu ZG
    Bing Du Xue Bao; 2008 Jan; 24(1):47-52. PubMed ID: 18320822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease.
    Mire CE; Geisbert JB; Agans KN; Versteeg KM; Deer DJ; Satterfield BA; Fenton KA; Geisbert TW
    Emerg Infect Dis; 2019 Jun; 25(6):1144-1152. PubMed ID: 31107231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters.
    van Doremalen N; Lambe T; Sebastian S; Bushmaker T; Fischer R; Feldmann F; Haddock E; Letko M; Avanzato VA; Rissanen I; LaCasse R; Scott D; Bowden TA; Gilbert S; Munster V
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007462. PubMed ID: 31170144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8.
    Watanabe S; Yoshikawa T; Kaku Y; Kurosu T; Fukushi S; Sugimoto S; Nishisaka Y; Fuji H; Marsh G; Maeda K; Ebihara H; Morikawa S; Shimojima M; Saijo M
    PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011851. PubMed ID: 38100536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development.
    Loomis RJ; Stewart-Jones GBE; Tsybovsky Y; Caringal RT; Morabito KM; McLellan JS; Chamberlain AL; Nugent ST; Hutchinson GB; Kueltzo LA; Mascola JR; Graham BS
    Front Immunol; 2020; 11():842. PubMed ID: 32595632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.